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Purpose: Bone morphogenetic protein 2 (BMP-2) is a member of the main subgroup of bone morphogenetic proteins
within the transforming growth factor-β superfamily. BMP-2 is involved in numerous cellular functions including
development, cell proliferation, apoptosis, and extracellular matrix synthesis. We examined BMP-2 expression in human
scleral fibroblasts (HSF) and assessed the effects of recombinant human BMP-2 (rhBMP-2) on HSF proliferation, matrix
metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinase-2 (TIMP-2).
Methods: We used confocal fluorescence microscopy (CFM) to study BMP-2 distribution in HSF cells and frozen human
scleral sections. The influence of rhBMP-2 on cell proliferation at different concentrations (0 ng/ml, 1 ng/ml, 10 ng/ml,
and 100 ng/ml) was evaluated by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The
effects of rhBMP-2 on the cell cycle were investigated with flow cytometric analysis. Reverse transcription polymerase
chain reaction (RT–PCR) and enzyme-linked immunosorbent assay (ELISA) were used to examine MMP-2 and TIMP-2
mRNAs and secreted proteins in HSF that were incubated with rhBMP-2.
Results: BMP-2 protein expression from human sclera was confirmed by CFM. Cell proliferation was significantly
increased with 100 ng/ml rhBMP-2 in a time-dependent manner (p<0.05). The HSF cell cycle moved to the S and S
+G2M phases after rhBMP-2 stimulation at 100 ng/ml compared to normal cells (p<0.05). TIMP-2 mRNA levels were
significantly increased in HSF incubated for 24 h with 100 ng/ml rhBMP-2 (p<0.01). A 48 h incubation with 10 ng/ml or
100 ng/ml rhBMP-2 resulted in significantly increased TIMP-2 mRNA and protein expression and significantly decreased
MMP-2 mRNA expression (p<0.01) while MMP-2 protein expression significantly decreased at 100 ng/ml rhBMP-2
(p<0.01).
Conclusions: Human sclera fibroblasts expressed BMP-2, which  promoted cell  proliferation,  and elicited changes in
MMP-2 and TIMP-2, might influence extracellular matrix synthesis.
Scleral fibroblasts are involved in scleral remodeling,
which occurs during axial elongation in myopia [1-3]. Many
aspects  of  scleral  extracellular  matrix  remodeling  and
fibroblast  proliferation  are  regulated  by  specific  growth
factors  including  transforming  growth  factor-β  (TGF-β),
insulin-like growth factors I and II (IGF-I and IGF-II), and
basic  fibroblast  growth  factor  (bFGF)  [4-6].  The  matrix
metalloproteinase-2  (MMP-2)  and  tissue  inhibitor  of
metalloproteinase-2 (TIMP-2) proteoglycans are involved in
scleral extracellular matrix remodeling events associated with
eye growth under both normal and myopic conditions [7,8].
Bone  morphogenetic  proteins  (BMPs)  are  subgroups
from the transforming growth factor-β (TGF-β) superfamily
and have numerous cellular functions including development,
morphogenesis, cell proliferation, apoptosis, and extracellular
matrix synthesis [9]. Recent research suggests that BMPs have
multiple body functions and are frequently designated “body
morphogenetic  proteins”  [10].  BMP-2  is  a  bone
morphogenetic protein and is also a potent osteoinductive
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cytokine. It induces bone and cartilage formation, controls
fibroblast  apoptosis,  and  regulates  extracellular  matrix
synthesis  in  many  tissues  [11,12].  Additionally,  BMP-2
expression has been detected in both adult and embryonic
tissues of the cornea, the trabecular meshwork, the optic nerve
head, the retina, and the conjunctiva [13-15]. Recent studies
have  suggested  that  BMP-2  is  possibly  involved  in  the
pathophysiology of several ocular diseases [14-16].
Previous  studies  have  not  confirmed  the  presence  of
BMPs  in  the  human  sclera.  We  examined  human  scleral
fibroblasts (HSF) for BMP-2 and examined the effects of
recombinant  human  BMP-2  on  HSF  proliferation  and
extracellular matrix synthesis in this study.
METHODS
Tissue  source:  This  study  was  approved  by  the  Ethics
Committee of Sun Yat-sen University (Guangzhou, China)
and complied with the tenets of the Declaration of Helsinki
for biomedical research involving human subjects. Healthy
adult human eyes (n=4) from donors (age range 18–23 years)
were  obtained  from  the  Eye  Bank  of  the  Zhongshan
Ophthalmic Center (Sun Yat-sen University). The specimens
were numbered 1-4.
Molecular Vision 2008; 14:2373-2380 <http://www.molvis.org/molvis/v14/a274>
Received 18 September 2008 | Accepted 8 December 2008 | Published 18 December 2008
© 2008 Molecular Vision
2373Sample sclera preparation: The anterior segments, vitreous
bodies, choroids, and retinas were removed from specimens
1 and 2. The posterior sclera was cut into 5×5 mm2 pieces,
embedded  with  optimum  cutting  temperature  compound
(Sigma, St. Louis, MO), and cut into 5 μm sections at −20 °C.
Sections were subsequently tiled onto slides (Corning Ltd,
Tokyo, Japan), fixed with cool acetone for 15 min, air-dried,
and kept frozen at −20 °C until use.
Human  scleral  fibroblast  isolation,  culture,  and
identification: Specimens 3 and 4 were washed immediately
in Hank's balanced salt solution (HBSS, Gibco, Grand Island,
NY) with penicillin (200 ug/ml; Invitrogen Corp, Carlsbad,
CA) and gentamicin sulfate (400 μg/ml; Invitrogen Corp,
Carlsbad, CA). All eye contents were removed except the
sclera. The sclera were trimmed into 1×1 mm pieces, placed
in  25  mm2  plastic  culture  bottles  in  Dulbecco’s  modified
Eagle's  medium  (DMEM,  Gibco)  with  1X  antibiotic/
antimycotic (Invitrogen Corp), and 10% fetal bovine serum
(FBS,  Gibco),  and  incubated  at  37  °C  in  a  humidified
incubator  containing  5%  CO2.  The  growth  medium  was
changed every three days, and upon achievement of a heavy
primary monolayer, the cells were trypsinized for 2 min at
room  temperature  in  0.25%  trypsin/EDTA  solution  in
phosphate  buffered  saline  (PBS,  Gibco).  Cells  were
subcultured at a split ratio of 1:3 in a 25 mm2 plastic bottle
(Corning Ltd), and the third fibroblast passage was used for
this experiment. The fibroblasts were grown on coverslips in
six well plates (Corning Ltd) to 70%-80% confluence. The
cells were washed with PBS three times, fixed with cool
acetone for 15 min, air-dried, and kept frozen at −20 °C until
use. HSF morphology was observed with light microscopy.
The  purity  of  fibroblast  cell  cultures  was  confirmed  by
staining  for  vimentin  and  stain  resistance  for  cytokeratin,
desmin,  and  S-100  in  the  indirect  immunofluorescence
procedure as previously described [17].
Indirect immunofluorescence: The slides were washed three
times with PBS, covered with 10% normal goat serum (Boster
Biological Technology, Wuhan, China) diluted in PBS, and
incubated for 20 min at 37 °C. The slides were incubated at
4 °C overnight with primary antibodies (anti-BMP-2; Boster
Biological Technology) diluted to 1:500 in PBS. Cells were
incubated in PBS without primary antibodies as a negative
control. The antibody-treated and negative control sample
slides were washed with PBS and exposed to fluorescein
isothiocyanate-conjugated  (FITC)  goat  anti-rabbit  IgG
antibodies (Boster Biological Technology) diluted at 1:50 in
PBS at 37 °C for 30 min. The slides were washed with PBS
three times and stained with propidium iodide (Sigma) and
Hoechst  33342  (Sigma)  to  stain  the  cell  nuclei.
Immunofluorescent  images  were  taken  with  a  confocal
microscope (LSM 510 META, Carl Zeiss, Jena, Germany).
Assay of BMP-2 on human sclera fibroblast proliferation and
cell cycles: The influence of cell proliferation was evaluated
by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT, Gibco) assay. Recombinant human BMP-2
(rhBMP-2; Peprotech Inc., Rocky Hill, NJ) was reconstituted
TABLE 1. PRIMER SEQUENCES USED IN POLYMERASE CHAIN REACTION.
Name GenBank accession
number Upstream primer Downstream primer
Size
(bp)
MMP-2 NM_001127891 ATGCGGAAGCCACGCTGCG AGCGGTAGCCATCCGTGCG 657
TIMP-2 NM_003255 TACCAGATGGGCTGCGAGTG TCCAGGAAGGGATGTCAGAG 305
β-actin NM_001101 CCTAGAAGCATTGCGTGG GAGCTACGAGCTGCCTGACG 513
Figure 1. Distribution of BMP-2 in human sclera by indirect immunofluorescence. FITC marked the secondary antibody (green; A) and
Hoechst33342 dyed the nucleus (blue; B). The first (A) and second images (B) are combined to form the third image shown (C). BMP-2 is
localized in the cytoplasm of HSF and extracellular matrices (A-C). Magnification: 400X.
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2374in water containing bovine serum albumin (BSA; Sigma) to a
concentration of 0.1 mg/ml, and this solution was diluted into
DMEM to different concentrations and stored at 4 °C for
immediate  use  or  frozen  in  aliquots  at  −20  °C.  The  first
passage cells were plated in standard flat-bottomed 96 well
plates (Corning Ltd) with DMEM in 10% FBS at a 4,000 cells/
cm2 density. Before treated with rhBMP-2 or control BSA, the
medium was changed to DMEM without FBS for 24 h after
initial plating. The culture media were replaced by various
media containing test agents after an incubation of 24 h. Cells
were incubated at 37 °C for one to seven successive days, and
rhBMP-2 and control samples were replaced with fresh agents
daily. Cells were washed twice with 10 mmol/l PBS (pH 7.2)
and incubated with 0.5 mg/ml MTT for the last 4 h before the
end of the incubation. The medium was decanted, formazan
salts were dissolved with 200 µl dimethyl sulfoxide (DMSO,
Sigma), and the absorbance was determined at 490 nm using
an  enzyme  linked  immunosorbent  assay  (ELISA)  reader
(BIO-TEK Instruments, Winooski, VT).
The rhBMP-2 effects on the cell cycle were investigated
by flow cytometry. The HSF were stimulated with 100 ng/ml
rhBMP-2, and the control group was trypsinized. Cells were
centrifuged for 5 min at 600x g, washed with PBS, and fixed
with ice-cold 70% (v/v) ethanol. Cells were washed twice with
PBS,  treated  with  25  units  RNase  (Sigma)  at  room
temperature for 10 min and finally resuspended in PBS with
50 μg/ml propidium iodide. DNA fluorescence was measured
with  a  FACSCalibur  Flow  Cytometry  System  (Becton-
Dickinson immunocytometer systems, San Jose, CA). The
cell cycle distribution by FACS data was analyzed using the
ModFit LT software (Verity Software House, Topsham, ME).
Reverse transcription polymerase chain reaction for mRNA
expression of MMP-2 and TIMP-2: The MMP-2 and TIMP-2
mRNA  expression  values  were  determined  with  reverse
Figure 2. Distribution of BMP-2 in human sclera fibroblasts in vitro using indirect immunofluorescence. FITC marked the secondary antibody
(green; A), and PI dyed the nucleus (red; B). The first (A) and second images (B) are combined to form the third image shown (C). BMP-2
is localized in the cytoplasm and weakly in the nucleus of HSF (A-C). Magnification: 400X.
Figure 3. The changed pattern of human sclera fibroblasts incubated with rhBMP-2. The HSFs showed only a sparse and vortex pattern before
incubation (A) whereas incubation with 100 ng/ml rhBMP-2 changed the HSFs into the intensive and polygonal cells (B). Inverted phase
contrast microscope, original magnification 100X.
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2375transcription polymerase chain reaction (RT–PCR) with β-
actin amplification as a control. Human sclera fibroblasts
were seeded in 75 cm2 Nunc culture bottles at a density of
1×106 cells per bottle and cultured for 24 h.
Various concentrations of rhBMP-2 (0 ng/ml, 1 ng/ml, 10
ng/ml,  and  100  ng/ml)  were  added  to  samples  after
synchronization of HSF cells in DMEM without FBS for 24
h as described in the MTT assay. The control group was
incubated  without  the  addition  of  drugs.  Total  RNA  was
extracted from cells with TRIzol reagent (Invitrogen) after 12
h, 24 h, and 48 h incubation, and cDNA was synthesized with
5 µg total RNA, 1 µl random primer, 2 µl dNTPs, and 200 U
MMLV Reverse Transcriptase (Promega, Madison, WI) at
37 °C for 1 h. MMP-2 and TIMP-2 mRNAs were detected by
RT–PCR. The nucleotide sequences of the primers used in the
experiments  and  the  GenBank  accession  number  of  the
underlying sequences are denoted in Table 1. Amplification
was  as  follows  30  denaturing  cycles  at  94  °C  for  45  s,
annealing cycles at 59 °C for 30 s, and an extension cycle at
72 °C for 60 s. The reaction mixture (25 µl) contained 3 µl
cDNA, 25 pmol of each primer, 0.25 mmol dNTPs, and 2 U
of  Taq  DNA  polymerase  (Promega).  PCR  products  were
analyzed with 1% agarose gel electrophoresis and visualized
with ethidium bromide staining. PCR product fragment sizes
produced were 657 bp (MMP-2), 305 bp (TIMP-2), and 513
bp (β-actin). All RT–PCR products were compared to β-actin
cDNA products from corresponding samples, and all band
intensities were evaluated by densitometry.
Enzyme-linked immunosorbent assay: MMP-2 and TIMP-2
proteins secreted from primary HSF cells were incubated with
0 ng/ml, 1 ng/ml, 10 ng/ml, and 100 ng/ml rhBMP-2 after 12
h, 24 h, and 48 h. Proteins were assayed with commercially
available enzyme-linked immunosorbent assay (ELISA) kits
(USCN Life Science & Technology Company, Double Lake,
MO). Conditioned media from the primary HSF cell culture
were used in a 1:100 dilution to ensure that MMP-2 and
TIMP-2 levels fell within the standard assay ranges. Lower
detection limits were 0.390 ng/ml (MMP-2) and 0.312 ng/ml
TABLE 2. THE EFFECT OF RHBMP-2 ON HSF PROLIFERATION AT DIFFERENT
CONCENTRATIONS AFTER FIVE DAYS.
Group Concentration A value (X±s)
1 0.00 ng/ml 0.2911±0.039
2 0.1 ng/ml 0.2996±0.056
3 1 ng/ml 0.2953±0.075
4 10 ng/ml 0.3023±0.032
5 100 ng/ml 0.3721±03042*
HSF proliferation in the presence of rhBMP-2 (100ng/ml) was
significantly  higher on day 5 than those of different rhBMP-2
concentrations or controls (p<0.05). Absorbance value (A
value) at a wavelength of 490 nm and the mean±SD (X±s) is
provided for each point (n=8) on day 5. An asterisk indicates
p<0.05 when compared to the control group.
(TIMP-2).  There  was  no  significant  cross-reactivity  or
interference, and the intra-assay and inter-assay variability
was less than 5% according to the manufacturer's description.
All samples were assayed, and the 450 nm optical density
(OD) was determined with an ELISA reader. Human MMP-2
and  TIMP-2  from  conditioned  media  were  quantified  in
duplicate with double-sandwich ELISA kits according to the
manufacturer’s protocol. The levels of secreted MMP-2 and
TIMP-2 were expressed as ng/ml values.
Statistical  analysis:  Data  were  expressed  as  the  mean
±standard deviation (SD). The Student’s t-test was performed
for statistical analysis of cytometry between the experiment
and control groups. Groups were compared by using a one-
way analysis of variance (ANOVA) with a Tukey post hoc
test  where  p<0.05  indicated  a  statistically  significant
difference. All analyses were performed with software (SPSS
version 12.0; SPSS, Chicago, IL).
Figure  4.  Time-dependent  effects  of  rhBMP-2  on  the  cell
proliferation  of  primary  cultured  human  sclera  fibroblasts.  Cell
proliferation was determined by MTT assay. The optical density
value at A490 and the mean±SD is provided for each time point
(n=8). The cells were incubated with no rhBMP-2 or 100 ng/ml
rhBMP-2 for seven days. A significant difference was seen in cell
proliferation between 100 ng/ml rhBMP-2 treatment and control
after four days. The asterisk indicates that p<0.05 when compared
with the control without rhBMP-2.
TABLE 3. RESULTS OF CYTOMETRY ANALYSIS.
Group G1 S G2M Pr I (S+G2M)
Control 84.3% 6.4% 9.3% 15.7%
Experiment 61.3%* 18.9%* 19.8% 38.7%*
The  HSF  percentage  was  increased  in  the  S  phase  and
decreased  in the Gl phase when the cells were stimulated with
100 ng/ml BMP-2. Additionally, the Proliferation Index (Pr
I(S+G 2M))  was  also  significantly  increased.  Proliferation
index (Pr I) indicates the vability of cell proliferation, Pr I =(S
+G2M)/(G 0/G1+S+G 2M). An asterisk indicates p<0.05 when
compared to the control group.
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2376RESULTS
BMP-2 expression in scleral cytoplasm and tissues: In vivo,
BMP-2  levels  were  uniformly  expressed  in  the  HSF
cytoplasm and extracellular matrices of scleral tissue (Figure
1). In vitro, BMP-2 was expressed mainly in the cytoplasm of
primary cultured HSF and weak in the nuclei (Figure 2).
Affects of rhBMP-2 on cell proliferation and the cell cycle in
rhBMP-2 culture: The HSF migrated from pieces of sclera
tissue  and  populated  the  surroundings;  cells  exhibited  a
uniform, fusiform shape. Cell growth was arranged in a vortex
pattern (Figure 3A). The HSF pattern in cells exposed to
various concentrations of rhBMP-2 was polygonal (Figure
3B). HSF were exposed to various concentrations of rhBMP-2
(1 ng/ml, 10 ng/ml, and 100 ng/ml), and cells and controls
were  incubated  for  another  one  to  seven  days.  HSF
proliferation in the presence of rhBMP-2 (100 ng/ml) was
significantly higher on day 5 than those of different rhBMP-2
concentrations or controls (p<0.05; Table 2). The maximum
stimulatory effects on cell proliferation were achieved on day
5  through  day  7  when  rhBMP-2  was  at  a  100  ng/ml
concentration, although the increase was not significant on
day 1 through day 4 at the same concentration (Figure 4).
Stimulatory effects were not seen at other concentrations.
Flow cytometry analysis results revealed that the HSF
percentages were increased significantly (p<0.05) in the S
phase and decreased significantly (p<0.05) in the Gl phase
when  the  cells  were  stimulated  with  100  ng/ml  BMP-2.
Additionally,  the  Proliferation  Index  (Pr  I(S+G2M))  was
Figure 5. Effect of rhBMP-2 on mRNA
expression  levels  of  MMP-2  and
TIMP-2  in  human  sclera  fibroblasts.
Ethidium-bromide  agarose  gels
indicated the level of β-actin message
relative to MMP-2 (A) and TIMP-2 (B)
levels  from  total  RNA.  Bar  graphs
revealed changes in mRNA expression
(mean±standard  error  of  the  mean)
where values were normalized to β-actin
values and expression was stated as a
ratio  of  optical  density.  The  double
asterisk  means  that  the  semi-
quantitative  RT-PCR  revealed
significant  changes  for  MMP-2  and
TIMP-2 with varying concentrations of
rhBMP-2 (p<0.01).
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2377significantly higher in experiment group than that in control
group (p<0.05; Table 3).
Changes in MMP-2 and TIMP-2 mRNA levels in rhBMP-2
culture: Relative MMP-2 and TIMP-2 mRNA levels were
markedly changed in BMP-2 cultures compared to β-actin
mRNA levels in the negative controls. No differences were
noted in the MMP-2 and TIMP-2 mRNA levels in HSF control
samples and in samples incubated with rhBMP-2 at varying
concentrations after 12 h. At 24 h, there was no significant
change in the MMP-2 mRNA level in any of the samples (all
p>0.05).  TIMP-2  mRNA  expression  in  HSF  cells  was
significantly increased in samples incubated with 100 ng/ml
rhBMP-2 (p=0.001). Significantly increased TIMP-2 mRNA
expression and decreased MMP-2 mRNA expression were
noted in HSF cells incubated with 100 ng/ml (both p=0.001)
or 10 ng/ml (both p=0.003) rhBMP-2 for 48 h (Figure 5).
Changes in MMP-2 and TIMP-2 protein levels in rhBMP-2
culture: There were no significant changes in secreted levels
of  MMP-2  and  TIMP-2  proteins  in  HSF  incubated  with
different rhBMP-2 concentrations after 24 h. The TIMP-2
protein  levels  were  significantly  increased  following
treatment of HSF cells with 100 ng/ml rhBMP-2 after 48 h
(p=0.001) and 10 ng/ml rhBMP-2 after 48 h (p=0.038) as seen
in Figure 6. MMP activities are regulated by TIMPs, and
therefore, the MMP-2 protein level at 100 ng/ml rhBMP-2 was
decreased significantly (p=0.044) as seen in Figure 7.
Figure 6. Effect of BMP-2 on TIMP-2
protein  secreted  from  human  sclera
fibroblasts into culture medium. Cells
were treated with 0, 1, 10, and 100 ng/
ml rhBMP-2 for 12, 24, and 48 h. There
were  no  significant  differences  in
secreted protein levels of TIMP-2 in the
HSF incubated with different rhBMP-2
concentrations after 24 h. The TIMP-2
protein  levels  were  significantly
increased following treatment with 100
ng/ml rhBMP-2 after 48 h (p< 0.01) and
10 ng/ml rhBMP-2 after 48 h (P < 0.05).
Data  were  represented  as  the  mean
±SEM.  Data  were  from  three
independent experiments. Each sample
was assayed in duplicate. An asterisk
indicates a p<0.05 compared to control
values, and a double asterisk indicates a
p< 0.01 compared to control values.
Figure 7. Effect of BMP-2 on MMP-2
protein  secretion  from  human  sclera
fibroblasts into culture medium. Cells
were treated with 0, 1, 10, and 100 ng/
ml rhBMP-2 for 12, 24, and 48 h. There
were  no  significant  differences  in
secreted protein levels of MMP-2 in the
HSF incubated with different rhBMP-2
concentrations after 24 h. The MMP-2
protein  levels  were  significantly
decreased following treatment of HSF
cells with 100 ng/ml rhBMP-2 after 48
h (p<0.05). Data were represented as the
mean±SEM.  Data  were  from  three
independent experiments. Each sample
was assayed in duplicate. An asterisk
indicates a p<0.05 compared to control
values.
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2378DISCUSSION
In  addition  to  previous  research  that  revealed  BMP-7
expression in the rat sclera [18], we provided evidence of
BMP-2 distribution in HSF and human sclera in this study.
Our study revealed that BMP-2 can be localized in HSF to the
nucleus  and  the  cytoplasm.  BMP-2  is  a  26  kDa  protein
composed of two identical 114 amino acid polypeptide chains
(monomers) linked by a single disulfide bond.
In our study, rhBMP-2 significantly promoted HSF cell
proliferation in vitro only at a concentration of 100 ng/ml, and
in  a  time-dependent  manner;  it  also  increased  the  HSF
percentage in the S and S+G2M phases and decreased the HSF
percentage  in  the  Gl  phase.  This  suggests  that  rhBMP-2
stimulated  mitosis  of  HSF  DNA  and  promoted  cell
proliferation as a result. BMP-2 is expressed in the human
cornea and is considered a heparin-binding cytokine that can
stimulate positive chemotaxis and modulate corneal fibroblast
apoptosis  [19].  The  alterations  in  the  scleral  fibroblast
population are involved in the modulation of scleral matrix
turnover  during  myopia  development  [20].  Accordingly,
BMP-2 is an important growth factor influence on HSF and
is possibly involved in the growth of human sclera.
Significantly  increased  expression  of  TIMP-2  and
decreased expression of MMP-2 in HSF after incubation with
rhBMP-2 were observed in our present study. These results
are  similar  to  those  in  a  recent  study  demonstrating  the
influence  of  rhBMP-2  on  MMP-2  and  TIMP-2  mRNA
expression  in  bone  regeneration  [21].  Human  scleral
fibroblasts express MMP-2 (gelatinase A, 72-kDa gelatinase,
Type IV collagenase) [22] and TIMP-2 [23]. MMP-2 is a
protein initially secreted as a pro-enzyme (ProMMP-2) and
converted to an active enzyme after cleavage (ActiveMMP-2).
TIMP-2 inhibits MMP-2 activation and MMP-2 activity by
blocking further cleavage of the pro-form active site cleft and
by blocking the catalytic domain of both active MMP-2 and
MMP-14 [24-26]. Scleral remodeling is a dynamic process
that  involves  continual  synthesis  and  degradation  of  the
extracellular matrix. Degradation of scleral connective tissue
during  remodeling  is  partially  regulated  by  the  balance
between  MMPs  and  TIMPs  [27,28].  Elevation  of  MMP
activity in the sclera by cytokines associated with HSF has
been implicated as a potential mechanism of tissue destruction
in myopia [28,29]. All these suggested that BMP-2 may act
as a cytokine in the control of scleral extracellular matrix
remodeling in myopia progression.
The human sclera is a dynamic tissue and is capable of
rapid responses to changes in the visual environment. It alters
ocular  size  and  refraction,  and  the  HSF  proliferation  and
scleral extracellular matrix remodeling events can result in
dramatic and immediate changes in biomechanical properties
of  the  sclera  and  subsequent  changes  in  ocular  length
[30-33]. A gene microarray analysis was used to identify gene
expression changes in human scleral fibroblasts in response
to  mechanical  loads  and  possible  mechanisms  of  scleral
remodeling in the development of myopia and showed that
mechanical stresses induced BMP-2 mRNA expression after
30 min and 24 h [30]. We detected BMP-2 protein in HSF,
and our data showed rhBMP-2 promotion of cell proliferation
and altered the expression of MMP-2 and TIMP-2 in HSF.
Our results suggest that BMP-2 may influence extracellular
matrix synthesis and scleral reconstruction, which contributes
to the development of human myopia. Further research on
BMP-2 and its effects on the alteration of scleral proteoglycan
and collagen synthesis and the control of ocular growth in
animal models will contribute to the increased understanding
of the remodeling of the sclera.
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